Click here for a complete list of CME opportunities.
The American Academy of HIV Medicine www.aahivm.org
Bibliography
Displaying 1711 - 1725 of 1754
Sprint Research Group, Wright JT, Jr., Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015; 373(22):2103-2116.
Wulff EA, Simpson DM. Neuromuscular complications of HIV-1 Infection. Curr Infect Dis Rep. 1999;1:192-197.
Wyatt C, Klotman P. Overview of kidney disease in HIV-infected patients. Available at http://www.uptodate.com/contents/overview-of-kidney-disease-in-hiv-infec.... Accessed August 5, 2014.
Wyatt CM, et al. The impact of hepatitis C virus co-infection on HIV-related kidney disease: A systematic review and meta-analysis. AIDS 14 (2008): 1799.
Wyatt CM, Morgello S, Katz-Malamed R, Wei C, Klotman ME, Klotman PE, et al. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney International 2009; 75(4):428-434.
Wyatt CM, Hoover DRM, Shi Q, et al. Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther. 2011;16:591-596.
Wyatt C, Klotman P. HIV-associated nephropathy (HIVAN). Available at http://www.uptodate.com/contents/hiv-associated-nephropathy-hivan?source.... Accessed August 5, 2014.
Xu L, Pozniak A, Wildfire A, et al. Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41. Antimicrob Agents Chemother. 2005;49:1113-1119.
Xu R. Effect of whey protein on the proliferation and differentiation of osteoblasts. J Dairy Sci 2009,92:3014-3018.
Yanagisawa N, Muramatsu T, Yamamoto Y, Tsuchiya K, Nitta K, Ajisawa A, et al. Classification of human immunodeficiency virus-infected patients with chronic kidney disease using a combination of proteinuria and estimated glomerular filtration rate. Clin Exp Nephrol 2014; 18(4):600-605. doi: 610.1007/s10157-10013-10853-10151. Epub 12013 Aug 10117.
Yang W, Kouyos R., Scherrer A, et al. Assessing the paradox between transmitted and acquired HIV type 1 drug resistance mutations in the Swiss HIV cohort study from 1998 to 2012. J Infect Dis. 2015;212:28-38.
Yarasheski, K E. Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy. Journal of Applied Physiology 90.1 (1985):133.
Yin MT, Shi Q, Hoover DR, et al. Fracture incidence in HIV-infected women: results from the Women’s Interagency HIV Study. AIDS 24.17 (2010):2679
Yin MT, Shiau S, Rimland D, et al. Fracture Prediction With Modified-FRAX in Older HIV-Infected and Uninfected Men. J Acquir Immune Defic Syndr.2016 Aug 15;72(5):513-20.
Yin MT, Falutz J. How to predict the risk of fracture in HIV? Curr Opin HIV AIDS 2016; 11(3):261-267.
Pages
Contact
AAHIVM National Office
1705 DeSales Street NW, Suite 700
Washington, D.C. 20036
About
The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.